Gd-EOB-DTPA-enhanced MR imaging: Evaluation of hepatic enhancement effects in normal and cirrhotic livers

European Journal of Radiology

Volumn 80, Issue 3, 2011, Pages

  Tamada, Tsutomu ^a   Ito, Katsuyoshi ^a   Higaki, Atsushi ^a   Yoshida, Koji ^a   Kanki, Akihiko ^a   Sato, Tomohiro ^a   Higashi, Hiroki ^a   Sone, Teruki ^a  

^a KAWASAKI MEDICAL SCHOOL   (Japan)

Author keywords

Comparative study; Gd EOB DTPA; Liver cirrhosis; Liver function; Magnetic resonance (MR)

Indexed keywords

GADOXETIC ACID;

AGED; ARTERIAL PHASE; ARTICLE; CHILD PUGH CLASS; CLINICAL ASSESSMENT; CLINICAL ASSESSMENT TOOL; CLINICAL EVALUATION; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DISEASE SEVERITY; EQUILIBRIUM PHASE; FEMALE; HEPATOBILIARY PHASE; HUMAN; IMAGE ANALYSIS; LIVER CIRRHOSIS; LIVER PARENCHYMA; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PORTAL PHASE; PRIORITY JOURNAL; RADIOLOGICAL PARAMETERS; RELATIVE ENHANCEMENT;

ADULT; AGED; AGED, 80 AND OVER; CONTRAST MEDIA; FEMALE; GADOLINIUM DTPA; HUMANS; IMAGE ENHANCEMENT; LIVER; LIVER CIRRHOSIS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 80053644274     PISSN: 0720048X     EISSN: 18727727     Source Type: Journal    
DOI: 10.1016/j.ejrad.2011.01.020     Document Type: Article

References (31)

1. T.J. Vogl, S. Kümmel, and R. Hammerstingl Liver tumors: comparison of MR imaging with Gd-EOB-DTPA and Gd-DTPA Radiology 200 1 1996 59 67 (Pubitemid 26197732)
2. H.J. Weinmann, G. Schuhmann-Giampieri, H. Schmitt-Willich, H. Vogler, T. Frenzel, and H. Gries A new lipophilic gadolinium chelate as a tissue-specific contrast medium for MRI Magn Reson Med 22 2 1991 233 237
3. G. Schuhmann-Giampieri, H. Schmitt-Willich, W.R. Press, C. Negishi, H.J. Weinmann, and U. Speck Preclinical evaluation of Gd-EOB-DTPA as a contrast agent in MR imaging of the hepatobiliary system Radiology 183 1 1992 59 64
4. O. Clément, A. Mühler, V. Vexler, Y. Berthezne, and R.C. Brasch Gadolinium-ethoxybenzyl-DTPA, a new liver-specific magnetic resonance contrast agent. Kinetic and enhancement patterns in normal and cholestatic rats Invest Radiol 27 8 1992 612 619
5. S. Kogita, Y. Imai, and M. Okada Gd-EOB-DTPA-enhanced magnetic resonance images of hepatocellular carcinoma: correlation with histological grading and portal blood flow Eur Radiol 20 10 2010 2405 2413
6. T. Ichikawa, K. Saito, and N. Yoshioka Detection and characterization of focal liver lesions: a Japanese phase III, multicenter comparison between gadoxetic acid disodium-enhanced magnetic resonance imaging and contrast-enhanced computed tomography predominantly in patients with hepatocellular carcinoma and chronic liver disease Invest Radiol 45 3 2010 133 141
7. U. Motosugi, T. Ichikawa, and H. Sou Distinguishing hypervascular pseudolesions of the liver from hypervascular hepatocellular carcinomas with gadoxetic acid-enhanced MR imaging Radiology 256 1 2010 151 158
8. Y.K. Kim, C.S. Kim, Y.M. Han, and G. Park Detection of small hepatocellular carcinoma: can gadoxetic acid-enhanced magnetic resonance imaging replace combining gadopentetate dimeglumine-enhanced and superparamagnetic iron oxide-enhanced magnetic resonance imaging? Invest Radiol 45 11 2010 740 746
9. A. Huppertz, T. Balzer, and A. Blakeborough Improved detection of focal liver lesions at MR imaging: multicenter comparison of gadoxetic acid-enhanced MR images with intraoperative findings Radiology 230 1 2004 266 275 (Pubitemid 37549812)
10. R. Hammerstingl, A. Huppertz, and J. Breuer Diagnostic efficacy of gadoxetic acid (primovist)-enhanced MRI and spiral CT for a therapeutic strategy: comparison with intraoperative and histopathologic findings in focal liver lesions Eur Radiol 18 3 2008 457 467 (Pubitemid 351248177)
11. J.E. van Montfoort, B. Stieger, D.K. Meijer, H.J. Weinmann, P.J. Meier, and K.E. Fattinger Hepatic uptake of the magnetic resonance imaging contrast agent gadoxetate by the organic anion transporting polypeptide Oatp1 J Pharmacol Exp Ther 290 1 1999 153 157 (Pubitemid 29302315)
12. F.T. Tschirch, A. Struwe, H. Petrowsky, I. Kakales, B. Marincek, and D. Weishaupt Contrast-enhanced MR cholangiography with Gd-EOB-DTPA in patients with liver cirrhosis: visualization of the biliary ducts in comparison with patients with normal liver parenchyma Eur Radiol 18 8 2008 1577 1586
13. T. Tajima, H. Takao, and H. Akai Relationship between liver function and liver signal intensity in hepatobiliary phase of gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid-enhanced magnetic resonance imaging J Comput Assist Tomogr 34 3 2010 362 366
14. U. Motosugi, T. Ichikawa, and H. Sou Liver parenchymal enhancement of hepatocyte-phase images in Gd-EOB-DTPA-enhanced MR imaging: which biological markers of the liver function affect the enhancement? J Magn Reson Imaging 30 5 2009 1042 1046
15. K. Ito, and D.G. Mitchell Imaging diagnosis of cirrhosis and chronic hepatitis Intervirology 47 3-5 2004 134 143 (Pubitemid 39279452)
16. Pieters PC, Miller WJ, DeMeo JH. Evaluation of the portal venous system: complementary roles of invasive and noninvasive imaging strategies. Radiographics; 17(4):879-95.
17. T. Kim, T. Murakami, and Y. Hasuike Experimental hepatic dysfunction: evaluation by MRI with Gd-EOB-DTPA J Magn Reson Imaging 7 4 1997 683 688 (Pubitemid 28365618)
18. Mühler A, Freise CE, Kuwatsuru R, et al. Acute liver rejection: evaluation with cell-directed MR contrast agents in a rat transplantation model. Radiology; 186(1):139-46.
19. H.K. Ryeom, S.H. Kim, and J.Y. Kim Quantitative evaluation of liver function with MRI Using Gd-EOB-DTPA Korean J Radiol 5 4 2004 231 239
20. N. Tsuda, M. Okada, and T. Murakami Potential of gadolinium-ethoxybenzyl- diethylenetriamine pentaacetic acid (Gd-EOB-DTPA) for differential diagnosis of nonalcoholic steatohepatitis and fatty liver in rats using magnetic resonance imaging Invest Radiol 42 4 2007 242 247 (Pubitemid 46398863)
21. A. Kitao, Y. Zen, and O. Matsui Hepatocellular carcinoma: signal intensity at gadoxetic acid-enhanced MR imaging - correlation with molecular transporters and histopathologic features Radiology 256 3 2010 817 826
22. A. Geier, C.G. Dietrich, and S. Voigt Effects of proinflammatory cytokines on rat organic anion transporters during toxic liver injury and cholestasis Hepatology 38 2 2003 345 354 (Pubitemid 36919855)
23. A. Geier, S.K. Kim, and T. Gerloff Hepatobiliary organic anion transporters are differentially regulated in acute toxic liver injury induced by carbon tetrachloride J Hepatol 37 2 2002 198 205 (Pubitemid 34833081)
24. C. Planchamp, X. Montet, and J.L. Frossard Magnetic resonance imaging with hepatospecific contrast agents in cirrhotic rat livers Invest Radiol 40 4 2005 187 194 (Pubitemid 40393229)
25. H. Popper Pathologic aspects of cirrhosis Am J Pathol 87 1 1997 228 264
26. J. Ward, and P.J. Robinson How to detect hepatocellular carcinoma in cirrhosis Eur Radiol 12 9 2002 2258 2272 (Pubitemid 36940322)
27. B.B. Frericks, C. Loddenkemper, and A. Huppertz Qualitative and quantitative evaluation of hepatocellular carcinoma and cirrhotic liver enhancement using Gd-EOB-DTPA AJR Am J Roentgenol 193 3 2009 1053 1060
28. T. Tamada, K. Ito, and T. Sone Dynamic contrast-enhanced magnetic resonance imaging of abdominal solid organ and major vessel: comparison of enhancement effect between Gd-EOB-DTPA and Gd-DTPA J Magn Reson Imaging 29 3 2009 636 640
29. J.B. Wong, W.G. Bennett, R.S. Koff, and S.G. Pauker Pretreatment evaluation of chronic hepatitis C: risks, benefits, and costs JAMA 280 24 1998 2088 2093 (Pubitemid 29014067)
30. B. Maharaj, R.J. Maharaj, and W.P. Leary Sampling variability and its influence on the diagnostic yield of percutaneous needle biopsy of the liver Lancet 1 8480 1986 523 525 (Pubitemid 16138427)
31. D.A. Aguirre, C.A. Behling, E. Alpert, T.I. Hassanein, and C.B. Sirlin Liver fibrosis: noninvasive diagnosis with double contrast material-enhanced MR imaging Radiology 239 2 2006 425 437